Cetera Investment Advisers Novartis Ag Transaction History

Cetera Investment Advisers

  • $44.2 Billion
  • Q3 2024

A detailed history of Cetera Investment Advisers transactions in Novartis Ag stock. As of the latest transaction made, Cetera Investment Advisers holds 113,885 shares of NVS stock, worth $11.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
113,885
Previous 109,656 3.86%
Holding current value
$11.2 Million
Previous $11.7 Million 12.22%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $448,823 - $511,243
4,229 Added 3.86%
113,885 $13.1 Million
Q2 2024

Aug 22, 2024
BUY
$92.57 - $107.37 $288,910 - $335,101
3,121 Added 2.93%
109,656 $11.7 Million
Q1 2024

May 24, 2024
BUY
$95.27 - $108.47 $9.44 Million - $10.7 Million
99,080 Added 1329.04%
106,535 $10.3 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $1.36 Million - $1.55 Million
-14,303 Reduced 65.74%
7,455 $721,000
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $103,434 - $113,826
-1,121 Reduced 4.9%
21,758 $2.2 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $103,634 - $115,012
1,094 Added 5.02%
22,879 $2.33 Million
Q2 2023

Aug 09, 2023
BUY
$92.52 - $104.91 $292,363 - $331,515
3,160 Added 16.97%
21,785 $2.2 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $63,783 - $73,969
-797 Reduced 4.1%
18,625 $1.71 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $717,573 - $878,754
9,498 Added 95.71%
19,422 $1.76 Million
Q3 2022

Nov 10, 2022
SELL
$74.61 - $87.26 $505,930 - $591,710
-6,781 Reduced 40.59%
9,924 $754,000
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $65,301 - $76,031
811 Added 5.1%
16,705 $1.41 Million
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $46,624 - $52,740
-582 Reduced 3.53%
15,894 $1.4 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $18,570 - $20,534
-233 Reduced 1.39%
16,476 $1.44 Million
Q3 2021

Nov 16, 2021
SELL
$81.78 - $95.14 $68,368 - $79,537
-836 Reduced 4.76%
16,709 $1.37 Million
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $53,615 - $59,220
629 Added 3.72%
17,545 $1.6 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $139,027 - $163,952
-1,665 Reduced 8.96%
16,916 $1.45 Million
Q4 2020

Feb 17, 2021
BUY
$78.07 - $94.43 $1.25 Million - $1.52 Million
16,045 Added 632.69%
18,581 $1.76 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $20,452 - $22,659
-249 Reduced 8.94%
2,536 $220,000
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $3,965 - $4,463
-49 Reduced 1.73%
2,785 $243,000
Q1 2020

May 08, 2020
SELL
$70.67 - $99.01 $5,370 - $7,524
-76 Reduced 2.61%
2,834 $234,000
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $11,387 - $12,874
135 Added 4.86%
2,910 $269,000
Q3 2019

Nov 06, 2019
BUY
$85.54 - $94.26 $769 - $848
9 Added 0.33%
2,775 $240,000
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $34,231 - $42,131
454 Added 19.64%
2,766 $253,000
Q1 2019

May 06, 2019
BUY
$75.32 - $86.15 $174,139 - $199,178
2,312 New
2,312 $222,000
Q4 2018

Feb 15, 2019
SELL
$73.66 - $82.02 $181,719 - $202,343
-2,467 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $165,140 - $191,019
2,467 New
2,467 $212,000
Q4 2017

Feb 08, 2018
SELL
$72.33 - $77.64 $196,882 - $211,336
-2,722 Closed
0 $0
Q3 2017

Nov 16, 2017
SELL
$74.14 - $77.27 $10,305 - $10,740
-139 Reduced 4.86%
2,722 $233,000
Q2 2017

Aug 17, 2017
SELL
N/A
-2,480 Reduced 46.43%
2,861 $241,000
Q2 2017

Aug 14, 2017
BUY
N/A
5,341
5,341 $448,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email